Compared to age-matched normal BM, MM patients presented at diagnosis with significantly decreased numbers of BCP (both stage I and stage II), TBC/NBC and (both CD19+ and CD19−) nPC in their BM. This evidence concerns the gene CD19 and Miyoshi myopathy.